enVVeno Medical Corporation (NASDAQ: NVNO) is a late clinical-stage medical device company headquartered in Irvine, California. The company specializes in developing innovative bioprosthetic solutions to address Chronic Venous Disease (CVD), with a particular focus on Chronic Venous Insufficiency (CVI). enVVeno's product portfolio includes first-in-class venous valve technologies designed to improve blood flow in the legs and alleviate the symptoms of CVI.
-
VenoValve® - A first-in-class surgical replacement venous valve designed to treat severe CVI of the deep venous system in the leg. Currently undergoing evaluation in the SAVVE U.S. pivotal trial, it functions as a one-way valve to assist in propelling blood back to the heart and lungs.
-
enVVe® - A first-in-class, non-surgical, transcatheter-based replacement venous valve for the treatment of deep venous CVI. Undergoing pre-clinical testing, it is designed to improve blood flow in the leg by acting as a one-way valve.
You might also like
| Name | Position | External Roles | Short Bio | |
|---|---|---|---|---|
Robert A. Berman ExecutiveBoard | Chief Executive Officer | Adjunct Faculty Member at Northwestern University School of Law | CEO of enVVeno Medical Corporation (NVNO) since April 2018. Previously, he led ITUS Corporation as President and CEO from September 2012 to July 2017 and served as COO and General Counsel at Acacia Research Corporation from 2000 to March 2007. | View Report → |
Craig Glynn Executive | Chief Financial Officer and Treasurer | Craig Glynn is the Chief Financial Officer and Treasurer at NVNO, having joined as interim CFO in April 2020 and becoming permanent CFO in January 2021. He brings over 39 years of financial services experience, including founding Edward Thomas Associates in 2012 and starting his career at Deloitte. | ||
Dr. Hamed Alavi Executive | Senior Vice President and Chief Technology Officer | Dr. Hamed Alavi is the Senior Vice President and Chief Technology Officer at NVNO since 2020. Previously, he held roles such as Director, Research, Development and Quality starting in July 2020 and Vice President of Research, Development and Quality starting in January 2021 at NVNO, and has contributed in leadership positions at NaviGate Cardiac Structures Inc., Medtronic, and Edwards Lifesciences. | ||
Marc H. Glickman Executive | Senior Vice President and Chief Medical Officer | Marc H. Glickman has been the Senior Vice President and Chief Medical Officer at NVNO since May 2016, and he served as a board member from July 2016 to August 2017 with an extensive background in vascular surgery and advisory roles. |
No recent press releases or 8-K filings found for NVNO.